Keywords: Nycomed, Instanyl, breakthrough pain, research

Instanyl sets new standard in breakthrough cancer pain, says Nycomed

Article | 11 September 2009

Print This

New data further demonstrate the efficacy of Swiss drugmaker Nycomed’s Instanyl (intranasal fentanyl spray) in the management of breakthrough ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in